Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02946892 · ClinicalTrials.gov registry record · Phase 4
Effect of Carvedilol on Exercise Performance in Fontan Patients
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
NCT02946892 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 26 participants.
The verdict
NCT02946892, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study evaluates the effect of carvedilol in patients who have undergone a Fontan heart operation. All participants will receive carvedilol and placebo for 12 weeks. Exercise tests will be performed at the end of each 12 week period.
Interventions
- DRUG Placebo
- DRUG Carvedilol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2016-11 |
| Est. Completion | 2020-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02946892
The ClinicalTrials.gov registry entry for NCT02946892 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02946892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02946892 about?
NCT02946892 is a clinical study titled "Effect of Carvedilol on Exercise Performance in Fontan Patients". This study evaluates the effect of carvedilol in patients who have undergone a Fontan heart operation. All participants will receive carvedilol and placebo for 12 weeks. Exercise tests will be performed at the end of each 12 week period.
What is the current status of trial NCT02946892?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2016-11. Estimated completion is 2020-01.
What interventions are being tested in trial NCT02946892?
The interventions under investigation include: Placebo (DRUG), Carvedilol (DRUG).
Who is sponsoring clinical trial NCT02946892?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.